Corteva Inc. (CTVA)

Corteva has been trading in a narrow band just above its 200-day average, and the next move will likely be decided by whether the stock can clear its 50-day average. The price of $12.17 sits 0.27% above the 200-day SMA of $12.14 and 2.48% below the 50-day SMA of $12.48, so the trend signals point in different directions. Analysts remain constructive: 11 of 13 rate the stock Buy, and the median 12-month target is $17.00. CleaRank's own rating is Hold, at 55 out of 100, because revenue shrank in the most recent available quarter and profitability trails the sector.

Of the six recent rating actions, three were reaffirmations of a constructive stance, and two of those were upgrades to a buy-type view. JP Morgan upgraded the stock to Overweight from Neutral on October 6, 2026, and Keybanc upgraded it to Overweight from Sector Weight on October 7, 2026. UBS kept its Neutral rating on October 12, 2026. Argus Research kept its Buy rating on September 18, 2026, and BMO Capital kept its Outperform rating on September 16, 2026. Citigroup kept its Neutral rating on September 17, 2026. Eleven of the 13 analysts with a current rating now rate the stock buy or strong buy, while 15 of 22 ratings three months earlier were buys. The shift toward Buy is real, but two analysts still hold a neutral view and none rate it sell.

Corteva beat the EPS estimate in six of its last seven reports. The July 30, 2026 report beat by 3.14%, with adjusted EPS of $2.30 against $2.23 expected, yet the stock fell 11.90% in the first session after that report. The May 5, 2026 report beat by 27.12% and the stock fell 2.54% the next session. In four of the six beats, the share price was lower in the first session after the report. Investors appear to be focused on sales and forward guidance rather than on the EPS beat alone.

At a price-to-sales ratio of 1.63, the stock trades 61.2% below the sector median P/S of 4.2, on a market capitalisation of $8.1B. That discount reflects weak fundamentals. Revenue growth trails the sector median of 19.0% by 20.2 percentage points, and the net profit margin is 2.5%, while return on equity of 4.49% sits well below the sector median of 17.9%. The debt-to-equity ratio of 0.57 is moderate. The trailing dividend yield is 5.92%, paid at an annual $0.72 per share, which gives income-focused holders a return while they wait for growth to come back.

Insiders sold $7.2M of stock across three sales over the last 18 months, and there were no open-market purchases in that period. Insider sales are often planned in advance or made to cover tax on vesting shares, so they carry less weight than purchases would. The RSI reads 48.7, which is neutral, and the MACD line is negative. The stock fell 8.08% over one month and rose 23.72% over one year, so the longer-term direction has been positive while the most recent month has been weak.

The base case for the coming months is a stock that stays range-bound while it proves it can grow again. The price needs to hold above the 200-day average and then reclaim the 50-day average to shift the trend signal to positive. Revenue growth is the main gap: the most recent available quarter shrank 1.20% year on year against a sector median of 19.0%, so analysts' expected 4.7% EPS growth for next year will need to show up in sales. Analysts' targets run from $13.65 to $20.00, with a median of $17.00, and that median assumes the growth case position out. A sustained break below the 200-day average would weaken the case and bring the $9.54 52-week low back into view as a reference. A clear move above the 50-day average, with momentum turning positive, would strengthen it. The CleaRank view is based on the figures above and is not a forecast.

Support: the 200-day SMA at $12.14 is the nearest level below the price, and a fall would meet it first. Below that, the 52-week low at $9.54 is the next floor, the level where the stock last bottomed. Resistance: the 20-day EMA at $12.19 sits just above the price and is the first level a rise would meet. The 50-day SMA at $12.48 comes next and is the level the trend signal depends on. Above it, the 52-week high at $14.62 is the level a sustained rally would have to reach.